ESMOND R. LONG
This content is PDF only. Please click on the PDF icon to access.
Vaccination against tuberculosis with BCG has been a debated subject for many years. The majority of the large number of investigators who have expressed themselves on the subject are favorable and many are highly enthusiastic toward its use. A minority, influential in professional standing, have opposed it, or at least urged caution and delay until further study furnishes unequivocal evidence of both its safety and value.
Part of the argument centers on the fact that BCG vaccine consists of live bacteria. The microörganism employed is an avirulent mutant from an originally virulent strain of tubercle bacillus, and in any long-range
LONG ER. BCG VACCINATION. Ann Intern Med. 1954;41:647–652. doi: 10.7326/0003-4819-41-3-647
Download citation file:
Published: Ann Intern Med. 1954;41(3):647-652.
Cardiac Diagnosis and Imaging, Cardiology, Infectious Disease, Vaccines/Immunization.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use